Search research articles
Contact Us
Filters
Showing results (51-60 of 122) with videos related to
Page
of 13
Sort By:
JCO Precision Oncology
|
June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome
Michele Bottosso, Benjamin Verret, Olivier Caron, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
February 2, 2017
Resting energy expenditure in the risk assessment of anticancer treatments
Anne Jouinot, Clara Vazeille, Jean Philippe Durand, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 26, 2023
Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors
Elisabeth Ashton, Jennifer Arrondeau, Anne Jouinot, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 9, 2018
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients
Rafael Reis, Laurence Labat, Marie Allard, et al.
Pharmaceutics
|
June 24, 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
Marie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
Journal of Translational Medicine
|
September 19, 2023
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
Alice Mogenet, Pascal Finetti, Emilie Denicolai, et al.
Cancers
|
January 11, 2022
Predicting Frailty and Geriatric Interventions in Older Cancer Patients: Performance of Two Screening Tools for Seven Frailty Definitions-ELCAPA Cohort
Claudia Martinez-Tapia, Marie Laurent, Elena Paillaud, et al.
Journal of Medical Genetics
|
October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options
Camille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
August 15, 2025
Early nutritional and inflammation assessment predicts prognosis in patients with cancer across tumor origin and metastatic status
Juliette Renard, Jean-Philippe Durand, Sixtine De Percin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2025
Machine Learning to Predict Mortality in Older Patients With Cancer: Development and External Validation of the Geriatric Cancer Scoring System Using Two Large French Cohorts
Etienne Audureau, Pierre Soubeyran, Claudia Martinez-Tapia, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 122) with videos related to
Sort By:
Page
of 13
JCO Precision Oncology
|
June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni Syndrome
Michele Bottosso, Benjamin Verret, Olivier Caron, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
February 2, 2017
Resting energy expenditure in the risk assessment of anticancer treatments
Anne Jouinot, Clara Vazeille, Jean Philippe Durand, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
April 26, 2023
Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors
Elisabeth Ashton, Jennifer Arrondeau, Anne Jouinot, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
June 9, 2018
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients
Rafael Reis, Laurence Labat, Marie Allard, et al.
Pharmaceutics
|
June 24, 2022
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients
Marie-Sophie Minot-This, Pascaline Boudou-Rouquette, Anne Jouinot, et al.
Journal of Translational Medicine
|
September 19, 2023
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
Alice Mogenet, Pascal Finetti, Emilie Denicolai, et al.
Cancers
|
January 11, 2022
Predicting Frailty and Geriatric Interventions in Older Cancer Patients: Performance of Two Screening Tools for Seven Frailty Definitions-ELCAPA Cohort
Claudia Martinez-Tapia, Marie Laurent, Elena Paillaud, et al.
Journal of Medical Genetics
|
October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options
Camille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
August 15, 2025
Early nutritional and inflammation assessment predicts prognosis in patients with cancer across tumor origin and metastatic status
Juliette Renard, Jean-Philippe Durand, Sixtine De Percin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2025
Machine Learning to Predict Mortality in Older Patients With Cancer: Development and External Validation of the Geriatric Cancer Scoring System Using Two Large French Cohorts
Etienne Audureau, Pierre Soubeyran, Claudia Martinez-Tapia, et al.
Page
of 13